Zomacton Kit
Product Images NDC 55566-1801

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Zomacton (NDC 55566-1801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Zomacton 01)

ZOMACTON 5 mg kit consisting of two vials: one labeled as liquid diluent and the other as the ZOMACTON drug product. Both vials have gray liquid inside and are designed for subcutaneous administration. The labeler is Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure B (Zomacton 02)

Illustration showing components of the ZOMACTON 10mg kit for subcutaneous use. It includes a syringe labeled as diluent, a vial labeled ZOMACTON 10mg, and a mixing needle. These components are used together for drug preparation.*

FDA Label Image

Figure C (Zomacton 03)

An instructional illustration showing a biohazard sharp container for disposal of syringe and needle, alongside an alcohol swab. The image emphasizes safe disposal and preparation materials commonly used in subcutaneous injections, relevant for products like ZOMACTON with somatropin.*

FDA Label Image

Figure D (Zomacton 04)

An instructional illustration showing two hands preparing an injection vial. One hand holds the vial steady on a surface, while the other hand lifts the cap off the vial, indicated by an upward arrow demonstrating the cap removal process. The image is indicative of medication preparation steps for subcutaneous administration.*

FDA Label Image

Figure E (Zomacton 05)

An instructional illustration showing two hands preparing a vial for injection. One hand holds a small vial while the other hand uses a wipe to clean the vial's rubber stopper, demonstrating proper injection preparation technique.*

FDA Label Image

Figure F (Zomacton 06)

An instructional illustration showing a syringe with a cap being removed. The image depicts the cap being pulled away and rotated downward, indicating how to uncover the syringe tip before use.*

FDA Label Image

Figure G (Zomacton 07)

Black and white line drawing showing hands preparing a syringe, with one hand holding the syringe and the other hand removing or placing a cap on the needle. This instructional figure depicts part of the subcutaneous injection preparation process.*

FDA Label Image

Figure H (Zomacton 08)

An instructional black-and-white line drawing showing a hand holding a vial and another hand inserting a syringe needle into the vial. The image illustrates the preparation of an injection, relevant to subcutaneous drug administration.*

FDA Label Image

Figure I (Zomacton 09)

An instructional illustration showing a person holding a syringe in one hand and using the other hand to remove the needle cap, demonstrating the preparation of an injection. This image is relevant for subcutaneous administration instructions, such as for ZOMACTON (somatropin) kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure J (Zomacton 10)

An instructional illustration showing a hand removing a cap by pulling upwards from a vertical pen injection device on the left, and on the right, a hand placing a needle onto the top of the pen device by pushing downwards. This likely depicts preparation steps for a subcutaneous injection pen, such as the ZOMACTON somatropin kit.*

FDA Label Image

Figure K (Zomacton 11)

Illustration showing a hand removing the cap from a vial, demonstrating preparation steps for subcutaneous administration. The image is consistent with instructions for the ZOMACTON somatropin kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure L (Zomacton 12)

An instructional illustration showing hands preparing a vial, with one hand holding the vial steady and the other hand placing a cap or stopper onto it. The image likely depicts a step in the preparation or administration process for a injectable medication such as ZOMACTON (somatropin) kit for subcutaneous use.*

FDA Label Image

Figure M (Zomacton 13)

An instructional line drawing showing hands preparing an injection. One hand holds a vial while the other hand draws medication from the vial into a syringe, demonstrating a step in subcutaneous drug administration for ZOMACTON (somatropin) kit.*

FDA Label Image

Figure N (Zomacton 14)

An instructional illustration showing the preparation of a subcutaneous injection, depicting a hand holding a syringe and another hand holding a vial with an arrow pointing upward to indicate the direction for drawing medication from the vial.*

FDA Label Image

Figure O (Zomacton 15)

An instructional illustration showing two hands preparing an injectable drug vial with a syringe, demonstrating the process of drawing medication from the vial.*

FDA Label Image

Figure P (Zomacton 16)

An instructional illustration showing two steps for preparing an injection. The first panel depicts a hand drawing medication into a syringe. The second panel shows a hand inserting a needle into a vial held by another hand, with an arrow indicating downward motion for injection or mixing. This image is related to the preparation steps for ZOMACTON somatropin injection kit.*

FDA Label Image

Figure Q (Zomacton 17)

An instructional diagram showing hands preparing a syringe by drawing medication from a vial. The image highlights proper technique for using the syringe, relevant for subcutaneous administration products like ZOMACTON (somatropin) kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure R (Zomacton 18)

An instructional diagram showing a hand holding a vial and a syringe needle being inserted upward into the vial's stopper. The illustration emphasizes preparation of an injection, likely for subcutaneous administration.*

FDA Label Image

Figure S (Zomacton 19)

Illustration showing front and back views of a human figure with multiple areas on the body marked, likely indicating recommended injection sites for subcutaneous administration. Marked areas include the abdomen, thighs, upper arms, and buttocks.*

FDA Label Image

Figure T (Zomacton 20)

An instructional illustration showing a person's hand holding a pen or injection device at a 90-degree angle to the skin on the opposite hand, demonstrating the proper technique for subcutaneous injection.*

FDA Label Image

Figure U (Zomacton 21)

An instructional line drawing showing two hands preparing a syringe by drawing liquid from a vial, illustrating a step in the subcutaneous injection process.*

FDA Label Image

Figure V (Zomacton 22)

An instructional illustration showing a hand holding a syringe at a 45 to 90-degree angle inserting the needle into the skin for a subcutaneous injection. This diagram demonstrates the proper technique for subcutaneous administration, relevant to ZOMACTON (somatropin) kit use.*

FDA Label Image

Principal Display Panel (5 mg Vial Label)

Packaging label for ZOMACTON 5 mg (somatropin) for Injection kit. The label is primarily white with blue accents and includes indications for subcutaneous use. Manufactured for Ferring Pharmaceuticals Inc., the label displays storage instructions, NDC 55566-1801-1, and a barcode. It also notes the product is made in Germany and includes details for reconstituting the injection.*

FDA Label Image

Principal Display Panel (5 mL Diluent Vial Label)

The packaging label for ZOMACTON 10 mg (somatropin) for Injection, a subcutaneous kit by Ferring Pharmaceuticals Inc. The label indicates the product contains one 10 mg vial of somatropin, one prefilled diluent syringe, and one needle attachment. Storage instructions and manufacturer details, including origin Germany, are also provided. The label features a blue and white design with orange accent text and includes barcodes and the Ferring Pharmaceuticals logo.*

FDA Label Image

Principal Display Panel (5 mg Kit Carton)

Packaging label for ZOMACTON 10 mg (somatropin) for injection, a human prescription drug for subcutaneous use. The label displays the product name, dosage strength, route, and includes instructions for use with the needle-free ZOMA-Jet 10 device. Manufactured for Ferring Pharmaceuticals Inc., the label also contains storage instructions and lot number information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.